Your medical briefing
Research, guidelines, and safety alerts for your specialty.
Recent updates in Dermatology from the last 30 days.
FDA has classified a Class II recall for THE ONE SPF 50 Invisible Sunscreen Gel (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), distributed by Allies Group Pte Ltd. The firm's testing indicated the affected product may not reliably provide the SPF 50 protection stated on its label.
Allies Group Inc. has recalled THE ONE SPF 50 Invisible Sunscreen Gel (avobenzone 3%, homosalate 7%, octocrylene 10%, octisalate 5%) in single-use 3ml sachets as a Class II recall. The firm's testing indicated the product may not reliably provide the SPF 50 protection stated on its label, according to the recall notice.
Allies Group Inc. has recalled THE ONE SPF 50 Invisible Sunscreen Gel (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), classified as a Class II recall. The company states that firm testing indicated the product may not reliably provide the SPF 50 protection stated on its label.
Allies Group Inc. has issued a Class II recall for THE ONE SPF 50 Invisible Sunscreen Gel, a 50ML tube containing avobenzone 3%, homosalate 7%, octocrylene 10%, and octisalate 5%. According to the firm's testing, the product may not reliably provide the SPF 50 protection stated on its label.
Lupin Pharmaceuticals has issued a Class II recall for Clobetasol Propionate Cream USP, 0.05%, 60 g tubes (NDC 68180-956-04), manufactured by Lupin Limited in India. The recall notice states the product failed content uniformity specifications, meaning the amount of active ingredient may not be consistent throughout the cream.
